Study on vine tea extract (AGE) highlights its anti-inflammatory, antioxidant, and immune-boosting properties. It also improves gut health and microbiota. Relevant for potential medical and dietary applications.
Exosomes contain microRNAs crucial for intercellular communication in neurodegenerative diseases. Traditional Chinese medicine monomers show promise in treating these diseases by reducing oxidative stress, apoptosis, and inflammation. Study explores their potential synergy with modern therapies.
This abstract summarizes the research progress of AG, a plant mainly found in China. It discusses its chemical components, therapeutic properties, and potential uses in various fields. This information can be useful for further research on AG.
Dihydromyricetin (DMY) is a compound found in Ampelopsis grossedentata that shows promise in treating diabetes mellitus (DM). It improves glucose and lipid metabolism, reduces inflammation and oxidative stress. The specific mechanisms and potential applications are still unclear.
This study found that supplementing Ampelopsis grossedentata flavonoids (AGF) in goat's diets improved rumen bacterial microbiome, plasma physiology, and growth performance. This has potential benefits for livestock growth and economic outcomes.
Vine tea has been consumed for centuries in China for various medicinal purposes. Leaves of Nekemias grossedentata are considered a new food resource.
Chronic social isolation is a psychological stressor that can induce neurobehavioral changes associated with anxiety disorders. This study observed the effects of social isolation on mitochondrial function and antioxidative enzymes. Treatment with dihydromyricetin counteracted the changes induced by social isolation on antioxidative enzymes, autophagy, and the BDNF-TrkB signaling pathway. These findings help explain the anxiolytic effects of dihydromyricetin and highlight the importance of oxidative stress in the pathogenesis of anxiety.
Anxiety disorders are prevalent and costly in the U.S. Despite available treatments, many patients experience side-effects or resistance. The COVID-19 pandemic has exacerbated the issue. Dihydromyricetin (DHM), a flavonoid found in Ampelopsis grossedentata, has been shown to have anxiolytic properties in mouse models. The authors investigated the effect of short-term social isolation on the neuroimmune system and found evidence that the GABAergic system plays a role in modulating immune response. These findings may lead to new therapies for anxiety disorders.
Researchers identified the key constituents in Ampelopsis grossedentata extract (AGE) responsible for inhibiting coronavirus 3C-like protease (3CL), a target for treating COVID-19. Flavonoid-rich fractions from AGE were found to strongly inhibit SARS-CoV-2-3CL, with dihydromyricetin, isodihydromyricetin, and myricetin identified as the most effective compounds. The researchers found that myricetin covalently binds to SARS-CoV-2-3CL at Cys300 and Cys44, while dihydromyricetin and isodihydromyricetin covalently bind at Cys300, suggesting that these compounds could be used to develop new antiviral agents.
Researchers investigated the effects of dihydromyricetin (DMY), a natural product found in Ampelopsis grossedentata, on brain aging in mice. The study found that DMY showed strong neuroprotective effects, improved spatial cognition, alleviated damage of hippocampal neurons, and inhibited senescence of hippocampal neurons. Additionally, DMY modulated oxidative stress and inflammation-related senescence of hippocampal neurons. These findings suggest that DMY may be a potential treatment for brain aging-related diseases.